Shaping smoking cessation in hard-to-treat smokers
- PMID: 20099951
- PMCID: PMC3623283
- DOI: 10.1037/a0018323
Shaping smoking cessation in hard-to-treat smokers
Abstract
Objective: Contingency management (CM) effectively treats addictions by providing abstinence incentives. However, CM fails for many who do not readily become abstinent and earn incentives. Shaping may improve outcomes in these hard-to-treat (HTT) individuals. Shaping sets intermediate criteria for incentive delivery between the present behavior and total abstinence. This should result in HTT individuals having improving, rather than poor, outcomes. We examined whether shaping improved outcomes in HTT smokers (never abstinent during a 10-visit baseline).
Method: Smokers were stratified into HTT (n = 96) and easier-to-treat (ETT [abstinent at least once during baseline]; n = 50) and randomly assigned to either CM or CM with shaping (CMS). CM provided incentives for breath carbon monoxide (CO) levels <4 ppm (approximately 1 day of abstinence). CMS shaped abstinence by providing incentives for COs lower than the 7th lowest of the participant's last 9 samples or <4 ppm. Interventions lasted for 60 successive weekday visits.
Results: Cluster analysis identified 4 groups of participants: stable successes, improving, deteriorating, and poor outcomes. In comparison with ETT, HTT participants were more likely to belong to 1 of the 2 unsuccessful clusters (odds ratio [OR] = 8.1, 95% CI [3.1, 21]). This difference was greater with CM (OR = 42, 95% CI [5.9, 307]) than with CMS, in which the difference between HTT and ETT participants was not significant. Assignment to CMS predicted membership in the improving (p = .002) as compared with the poor outcomes cluster.
Conclusion: Shaping can increase CM's effectiveness for HTT smokers.
Figures



Similar articles
-
The effects of percentile versus fixed criterion schedules on smoking with equal incentive magnitude for initial abstinence.Exp Clin Psychopharmacol. 2014 Aug;22(4):348-55. doi: 10.1037/a0036935. Epub 2014 May 19. Exp Clin Psychopharmacol. 2014. PMID: 24840638 Free PMC article. Clinical Trial.
-
Shaping smoking cessation using percentile schedules.Drug Alcohol Depend. 2004 Dec 7;76(3):247-59. doi: 10.1016/j.drugalcdep.2004.05.008. Drug Alcohol Depend. 2004. PMID: 15561476 Clinical Trial.
-
Improving contingency management programs for addiction.Addict Behav. 2004 May;29(3):507-23. doi: 10.1016/j.addbeh.2003.08.021. Addict Behav. 2004. PMID: 15050670
-
Nationwide access to an internet-based contingency management intervention to promote smoking cessation: a randomized controlled trial.Addiction. 2017 May;112(5):875-883. doi: 10.1111/add.13715. Epub 2017 Jan 25. Addiction. 2017. PMID: 27923264 Free PMC article. Clinical Trial.
-
Recent marijuana blunt smoking impacts carbon monoxide as a measure of adolescent tobacco abstinence.Subst Use Misuse. 2005;40(2):231-40. doi: 10.1081/ja-200048461. Subst Use Misuse. 2005. PMID: 15770886 Review.
Cited by
-
Determinants of choice, and vulnerability and recovery in addiction.Behav Processes. 2016 Jun;127:35-42. doi: 10.1016/j.beproc.2016.04.001. Epub 2016 Apr 12. Behav Processes. 2016. PMID: 27083500 Free PMC article. Review.
-
A randomized trial of contingency management for smoking cessation in the homeless.Psychol Addict Behav. 2018 Mar;32(2):141-148. doi: 10.1037/adb0000350. Epub 2018 Feb 19. Psychol Addict Behav. 2018. PMID: 29461070 Free PMC article. Clinical Trial.
-
Further psychometric analysis of the 20-item Partner Interaction Questionnaire in an adult sample of smokers.Psychol Addict Behav. 2019 Sep;33(6):567-573. doi: 10.1037/adb0000477. Epub 2019 Jun 13. Psychol Addict Behav. 2019. PMID: 31192622 Free PMC article.
-
Predicting successful 24-hr quit attempt in a smoking cessation intervention.Nicotine Tob Res. 2011 Nov;13(11):1092-7. doi: 10.1093/ntr/ntr151. Epub 2011 Aug 10. Nicotine Tob Res. 2011. PMID: 21832272 Free PMC article. Clinical Trial.
-
Addiction as a BAD, a Behavioral Allocation Disorder.Pharmacol Biochem Behav. 2018 Jan;164:62-70. doi: 10.1016/j.pbb.2017.05.002. Epub 2017 May 2. Pharmacol Biochem Behav. 2018. PMID: 28476485 Free PMC article. Review.
References
-
- Amodei N, Lamb RJ. Convergent and concurrent validity of the contemplation ladder and URICA scales. Drug and Alcohol Dependence. 2004;73:301–306. - PubMed
-
- Baer JS, Lichtenstein E. Classification and prediction of smoking relapse episodes: an exploration of individual differences. Journal of Consulting & Clinical Psychology. 1988;56(1):104–10. - PubMed
-
- Biener L, Abrams DB. The Contemplation Ladder: validation of a measure of readiness to consider smoking cessation. Health Psychology. 1991;10(5):360–365. - PubMed
-
- Condiotte MM, Lichtenstein E. Self-efficacy and relapse in smoking cessation programs. Journal of Consulting and Clinical Psychology. 1981;49:648–658. - PubMed